Cargando…

Pharmacological inhibition of USP7 suppresses growth and metastasis of melanoma cells in vitro and in vivo

Melanoma is a highly aggressive type of skin cancer. The development of diverse resistance mechanisms and severe adverse effects significantly limit the efficiency of current therapeutic approaches. Identification of the new therapeutic targets involved in the pathogenesis will benefit the developme...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xiang, Minmin, Liang, Long, Kuang, Xinwei, Xie, Zuozhong, Liu, Jing, Zhao, Shuang, Su, Juan, Chen, Xiang, Liu, Hong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8500953/ https://www.ncbi.nlm.nih.gov/pubmed/34469054 http://dx.doi.org/10.1111/jcmm.16834

Ejemplares similares

Potent USP10/13 antagonist spautin‐1 suppresses melanoma growth via ROS‐mediated DNA damage and exhibits synergy with cisplatin
por: Guo, Jia, et al.
Publicado: (2020)

Targeting melanoma residual disease by USP7
por: Vishnoi, Monika, et al.
Publicado: (2018)

Albendazole induces immunotherapy response by facilitating ubiquitin-mediated PD-L1 degradation
por: Zhu, Lin, et al.
Publicado: (2022)

USP7 substrates identified by proteomics analysis reveal the specificity of USP7
por: Nie, Litong, et al.
Publicado: (2022)

The inhibitory effect of 7,7″-dimethoxyagastisflavone on the metastasis of melanoma cells via the suppression of F-actin polymerization
por: Lin, Ching-Min, et al.
Publicado: (2016)

Usp5 links suppression of p53 and FAS levels in melanoma to the BRAF pathway
por: Potu, Harish, et al.
Publicado: (2014)

Pharmacological inhibition of USP7 promotes antitumor immunity and contributes to colon cancer therapy
por: Fu, Changqing, et al.
Publicado: (2019)

Research Trends in Immune Checkpoint Blockade for Melanoma: Visualization and Bibliometric Analysis
por: Xu, Yantao, et al.
Publicado: (2022)

TSPY1 suppresses USP7-mediated p53 function and promotes spermatogonial proliferation
por: Shen, Ying, et al.
Publicado: (2018)

USP7 inactivation suppresses APC-mutant intestinal hyperproliferation and tumor development
por: Novellasdemunt, Laura, et al.
Publicado: (2023)

CXCR7 regulates breast tumor metastasis and angiogenesis in vivo and in vitro
por: Qian, Tingting, et al.
Publicado: (2018)

Selective Inhibition of USP7
por: Menard, Robert, et al.
Publicado: (2012)

Suppression of USP7 induces BCR-ABL degradation and chronic myelogenous leukemia cell apoptosis
por: Jiang, Shuoyi, et al.
Publicado: (2021)

Therapeutic Efficacy of Pharmacological Ascorbate on Braf Inhibitor Resistant Melanoma Cells In Vitro and In Vivo
por: Niessner, Heike, et al.
Publicado: (2022)

Suppressive Effect of Juzen-Taiho-To on Lung Metastasis of B16 Melanoma Cells In Vivo
por: Matsuda, Takako, et al.
Publicado: (2011)

The deubiquitinase USP9X regulates FBW7 stability and suppresses colorectal cancer
por: Khan, Omar M., et al.
Publicado: (2018)

USP7 and USP47 deubiquitinases regulate NLRP3 inflammasome activation
por: Palazón‐Riquelme, Pablo, et al.
Publicado: (2018)

USP35 is a Potential Immunosuppressive Factor in Skin Cutaneous Melanoma
por: Zhang, Qian, et al.
Publicado: (2022)

Pharmacologic down-regulation of EZH2 suppresses bladder cancer in vitro and in vivo
por: Tang, Shou-Hung, et al.
Publicado: (2014)

Deubiquitylase USP7 regulates human terminal erythroid differentiation by stabilizing GATA1
por: Liang, Long, et al.
Publicado: (2019)

The regulation of NONO by USP11 via deubiquitination is linked to the proliferation of melanoma cells
por: Feng, Peifu, et al.
Publicado: (2020)

USP21 promotes cell proliferation and metastasis through suppressing EZH2 ubiquitination in bladder carcinoma
por: Chen, Yong, et al.
Publicado: (2017)

Inhibition of USP7 suppresses advanced glycation end-induced cell cycle arrest and senescence of human umbilical vein endothelial cells through ubiquitination of p53: USP7 inhibits ubiquitination of p53
por: Li, Xu, et al.
Publicado: (2022)

Overexpression of the Ubiquitin Specific Proteases USP43, USP41, USP27x and USP6 in Osteosarcoma Cell Lines: Inhibition of Osteosarcoma Tumor Growth and Lung Metastasis Development by the USP Antagonist PR619
por: Lavaud, Mélanie, et al.
Publicado: (2021)

Timosaponin AIII inhibits melanoma cell migration by suppressing COX‐2 and in vivo tumor metastasis
por: Kim, Ki Mo, et al.
Publicado: (2016)

USP7: Novel Drug Target in Cancer Therapy
por: Wang, Zhiru, et al.
Publicado: (2019)

Up‐regulated deubiquitinase USP4 plays an oncogenic role in melanoma
por: Guo, Weinan, et al.
Publicado: (2018)

Pharmacological activation of FOXO3 suppresses triple-negative breast cancer in vitro and in vivo
por: Park, See-Hyoung, et al.
Publicado: (2016)

BRD7 suppresses tumor chemosensitivity to CHK1 inhibitors by inhibiting USP1-mediated deubiquitination of CHK1
por: Li, Lemin, et al.
Publicado: (2023)

Inhibitory Effect of Melanoma Differentiation Associated Gene-7/Interleukin-24 on Invasion In Vitro of Human Melanoma Cancer Cells
por: Lin, Bi-wen, et al.
Publicado: (2013)

Moderate hyperglycemia suppresses melanoma metastasis to liver
por: Khoo, Celine Swee May, et al.
Publicado: (2022)

Modeling Melanoma In Vitro and In Vivo
por: Beaumont, Kimberley A., et al.
Publicado: (2013)

USP7-Dependent Regulation of TRAF Activation and Signaling by a Viral Interferon Regulatory Factor Homologue
por: Xiang, Qiwang, et al.
Publicado: (2020)

Potential diagnostic and prognostic marker dimethylglycine dehydrogenase (DMGDH) suppresses hepatocellular carcinoma metastasis in vitro and in vivo
por: Liu, Gang, et al.
Publicado: (2016)

Methionine deprivation suppresses triple-negative breast cancer metastasis in vitro and in vivo
por: Jeon, Hyein, et al.
Publicado: (2016)

Suppressive Effect of Juzentaihoto on Vascularization Induced by B16 Melanoma Cells In Vitro and In Vivo
por: Ishikawa, Shintaro, et al.
Publicado: (2012)

Betulinic acid induces apoptosis and suppresses metastasis in hepatocellular carcinoma cell lines in vitro and in vivo
por: Wang, Wei, et al.
Publicado: (2018)

Molecular mechanism for the substrate recognition of USP7
por: Cheng, Jingdong, et al.
Publicado: (2015)

Fbw7 and Usp28 – enemies and allies
por: Taranets, Lyudmyla, et al.
Publicado: (2015)

Highlights in USP7 inhibitors for cancer treatment
por: Oliveira, Rita I., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_gdsd5tr68m5dcn83281h5ul00n